GEN News Highlights: Oct 13, 2011

DNAnexus Raises $15M and Seals Cloud Storage Deal with Google to Host New SRA Database Repository

(Page 1 of 1)

    DNAnexus raised $15 million in a second round of financing led by Google Ventures and TPG Biotech, and separately announced a deal with Google that will allow DNAnexus to provide a freely accessible web-based interface for searching and accessing datasets in the public Sequence Read Archive (SRA) database. Through the deal with Google, the latter’s Google Cloud Storage will support hosting of the SRA data repository.

    The SRA has represented the main depot for data generated by DNA sequencing initiatives, including all primary sequence data for NIH-sponsored next-generation sequencing projects. However, DNAnexus explains, in February the National Center for Biotechnology Information (NCBI), which represents the major U.S. source of public genomic data, announced that it would phase out hosting support of the SRA in its current form due to federal funding cuts.

    The firm says its deal with Google will secure a new cloud-based repository that represents a mirrored site of the NCBI SRA website, and provide access to all publicly accessible datasets for specific studies, experiments, samples, and runs. DNAnexus claims its hosted SRA website will offer an intuitive interface for identifying and browsing datasets based on a range of query options, and users will also be able to download sequence read files—including all sequences from the 1,000 Genomes Project—for analysis using their own tools. “Combining Google’s massively scalable data storage infrastructure with DNAnexus’ expertise in web-based interfaces, genomics data analysis, and visualization, researchers can quickly access the world’s genomic information from any browser,” claims Eric Morse, head of business development at Google Cloud Storage.

    Users of the DNAnexus SRA website will in addition be able to import SRA datasets into the commercial DNAnexus platform, to enable additional functions such as mapping, RNA-seq, ChIP-seq, variant analysis, and data visualization, the firm adds. 


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

BLOG biotech

Webinars

GEN Podcasts

New Products

Best of the Web

GEN Polls

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll